Vitalhub Corp. has reported strong financial results for the period ending June 30, 2026, highlighted by a revenue increase to $31.7 million.. The company also expanded its European footprint through the acquisition of Buddy Healthcare, pushing its pro forma annual recurring revenue (ARR) beyond $106 million.
The $106 million ARR milestone and Buddy Healthcare
Vitalhub Corp. has officially crossed a major valuation threshold, with its pro forma annual recurring revenue reaching approximately $106.0 million following the acquisition of Buddy Healthcare. according to the company's interim financial statements, this growth is supported by a 10% annual organic ARR increase and an adjusted EBITDA that now represents 26% of total revenue.
The acquisition of Buddy Healthcare is specifically designed to enhance Vitalhub Corp.'s capabilities in patient journey optimization. By integrating this new entity, Vitalhub Corp. has effectively established a strategic beachhead in the Nordic region of Europe, diversifying its geographic reach beyond its established strongholds.
Scaling across 1,300 clients in Canada and the UK
The current expansion is part of a broader trend of consolidation within the health-tech sector, where platforms are racing to provide end-to-end administrative solutions. Vitalhub Corp. currently serves a diverse base of over 1,300 clients across Canada, the United Kingdom, and other international markets, positioning itself as a comprehensive software partner for health and human services providers.
As reported by the company, this scale has translated into significant top-line growth. Revenue for the period ended June 30, 2026, rose by 33% year-over-year to $31.7 million. This trajectory suggests that Vitalhub Corp. is successfully leveraging its existing client relationships to upsell its product suite while simultaneously entering new territories.
A $136.5 million cash reserve for aggressive M&A
Vitalhub Corp. is maintaining a highly liquid balance sheet to fuel its "two-pronged" growth strategy of organic product development and aggressive mergers and acquisitions. As of June 30, 2026, the company's cash, cash equivalents, and short-term investments grew to $136.5 million, up from $119.2 million at the end of 2025.
This financial cushion is paired with a sharp increase in profitability. The company's adjusted EBITDA jumped 83% year-over-year to $6.6 million, while net income before income taxes rose 62% to $3.6 million. These figures indicate that Vitalhub Corp. is not just growing its footprint, but is doing so with increasing operational efficiency .
The missing details of the Buddy Healthcare purchase price
Despite the optimistic financial reporting, several key details regarding the Buddy Healthcare deal remain undisclosed. The report does not specify the exact purchase price paid for the company, nor does it detail the specific terms of the acquisition, such as whether it was a cash-only deal or involved equity.
Furthermore, while the report mentions "patient journey optimization," it provides little technical detail on how Buddy Healthcare's specific tools integrate with the existing Vitalhub Corp. product suite. Investors will likely look for these specifics during the quarterly investor conference call scheduled for Friday, August 7, 2026, at 9:00am ET.
Comments 0